SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $752,000 | -21.7% | 432,259 | +0.4% | 0.28% | +24.9% |
| Q2 2015 | $961,000 | -32.9% | 430,749 | -41.7% | 0.22% | -16.6% |
| Q1 2015 | $1,433,000 | +18.2% | 738,748 | +61.5% | 0.26% | +19.9% |
| Q4 2014 | $1,212,000 | -9.3% | 457,458 | +3.1% | 0.22% | -8.7% |
| Q3 2014 | $1,336,000 | +8.1% | 443,871 | +46.8% | 0.24% | +22.8% |
| Q2 2014 | $1,236,000 | +45.8% | 302,296 | +53.7% | 0.20% | +60.2% |
| Q1 2014 | $848,000 | +114.1% | 196,639 | +160.1% | 0.12% | +123.6% |
| Q4 2013 | $396,000 | -15.7% | 75,614 | +1.5% | 0.06% | -25.7% |
| Q3 2013 | $470,000 | +28.1% | 74,480 | +1.2% | 0.07% | +13.8% |
| Q2 2013 | $367,000 | – | 73,585 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |